SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-04-000941
Filing Date
2004-03-15
Accepted
2004-03-15 17:20:34
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K w94839e10vk.htm 10-K 997952
3 EX-21.01 w94839exv21w01.htm EX-21.01 1807
4 EX-23.01 w94839exv23w01.htm EX-23.01 1738
5 EX-31.01 w94839exv31w01.htm EX-31.01 6614
6 EX-21.02 w94839exv31w02.htm EX-31.02 6637
7 EX-32.01 w94839exv32w01.htm EX-32.01 2039
8 EX-32.02 w94839exv32w02.htm EX-32.02 2250
  Complete submission text file 0000950133-04-000941.txt   1021102
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23736 | Film No.: 04670510
SIC: 2834 Pharmaceutical Preparations